Converge Bio has raised $5.5 million in seed funding led by TLV Partners.
WHAT IT DOES
Converge Bio is a generative AI hub for Biotech and Pharma that allows the accelerated discovery and development of drugs that use large language models (LLMs).
The platform supplies a library of foundational models across all biological languages that can be amplified and adjusted for specific tasks with...
Apple researchers have released a study highlighting the limitations of large language models (LLMs), concluding that LLMs' genuine logical reasoning is fragile and that there is "noticeable variance" in how models respond to different examples or representations of the same question.
The researchers analyzed the formal reasoning capabilities of LLMs, particularly in mathematics.
They noted...
A study performed by Google Research, in collaboration with Google DeepMind, reveals the tech giant expanded the capabilities of its AI models for Med-Gemini-2D, Med-Gemini-3D and Med-Gemini Polygenic.
Google said it fine-tuned Med-Gemini capabilities using histopathology, dermatology, 2D and 3D radiology, genomic and ophthalmology data.
The company's Med-Gemini-2 was trained on conventional...
Google made several announcements during its Check Up event on Tuesday, including the release of its new MedLM for Chest X-ray, advancements in personalization at Fitbit Labs and the release of its Skin Condition Image Network (SCIN).
Dr. Karen DeSalvo, Google Health's chief health officer, kicked off The Check Up event by highlighting the increased use of AI in healthcare.
"We are at an...
Google announced the release of MedLM, two foundational models built off Med-PaLM 2, designed to answer medical questions, generate insights from unstructured data and summarize medical information.
The tech giant said that through piloting its LLMs with healthcare organizations, it has learned the most effective AI models are designed to address specific use cases. Therefore, the large model...
